Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

Gish RG, Chang TT, Lai CL, de Man R, Gadano A, Poordad F, Yang J, Brett-Smith H, Tamez R.

J Viral Hepat. 2010 Jan;17(1):16-22. doi: 10.1111/j.1365-2893.2009.01146.x. Epub 2009 Jul 19.

PMID:
19622117
2.

Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B.

Chang TT, Chao YC, Gorbakov VV, Han KH, Gish RG, de Man R, Cheinquer H, Bessone F, Brett-Smith H, Tamez R.

J Viral Hepat. 2009 Nov;16(11):784-9. doi: 10.1111/j.1365-2893.2009.01142.x. Epub 2009 Apr 30.

PMID:
19457141
3.

Relapse of hepatitis B in HBeAg-negative chronic hepatitis B patients who discontinued successful entecavir treatment: the case for continuous antiviral therapy.

Shouval D, Lai CL, Chang TT, Cheinquer H, Martin P, Carosi G, Han S, Kaymakoglu S, Tamez R, Yang J, Tenney D, Brett-Smith H.

J Hepatol. 2009 Feb;50(2):289-95. doi: 10.1016/j.jhep.2008.10.017. Epub 2008 Nov 19.

PMID:
19070393
4.

Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.

Pessôa MG, Gazzard B, Huang AK, Brandão-Mello CE, Cassetti I, Mendes-Corrêa MC, Soriano V, Phiri P, Hall A, Brett-Smith H.

AIDS. 2008 Sep 12;22(14):1779-87. doi: 10.1097/QAD.0b013e32830b3ab5.

PMID:
18753861
5.

Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis.

Schiff E, Simsek H, Lee WM, Chao YC, Sette H Jr, Janssen HL, Han SH, Goodman Z, Yang J, Brett-Smith H, Tamez R.

Am J Gastroenterol. 2008 Nov;103(11):2776-83. doi: 10.1111/j.1572-0241.2008.02086.x. Epub 2008 Aug 21. Erratum in: Am J Gastroenterol. 2009 Feb;104(2):540.

PMID:
18721244
6.

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H.

Gastroenterology. 2007 Nov;133(5):1437-44. Epub 2007 Aug 14.

PMID:
17983800
7.

HIV as a chronic disease: implications for long-term care at an AIDS-dedicated skilled nursing facility.

Selwyn PA, Goulet JL, Molde S, Constantino J, Fennie KP, Wetherill P, Gaughan DM, Brett-Smith H, Kennedy C.

J Urban Health. 2000 Jun;77(2):187-203.

8.
9.
10.

Cytomegalovirus as a primary pulmonary pathogen in AIDS.

Waxman AB, Goldie SJ, Brett-Smith H, Matthay RA.

Chest. 1997 Jan;111(1):128-34.

PMID:
8996006
11.

Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia.

Griffith BP, Brett-Smith H, Kim G, Mellors JW, Chacko TM, Garner RB, Cheng YC, Alcabes P, Friedland G.

J Infect Dis. 1996 May;173(5):1252-5.

PMID:
8627080
12.

Treatment of encainide proarrhythmia with hypertonic saline.

Gardner ML, Brett-Smith H, Batsford WP.

Pacing Clin Electrophysiol. 1990 Oct;13(10):1232-5.

PMID:
1701536

Supplemental Content

Loading ...
Support Center